Advanced Technologies for Developing the State-of-the-Art Nanomedicines
Deadline for manuscript submissions: closed (20 November 2022) | Viewed by 22631
Interests: nanomedicines; peptide self-assembly; mitochondria
Interests: nanomedicines; biomaterials; drug delivery
Special Issues, Collections and Topics in MDPI journals
The past two decades have witnessed the rapid development of nanomedicines for antitumor therapy. In addition to antitumor therapy, nanomedicines also emerge as promising drugs for other devastating diseases including cerebro-cardiovascular diseases, central nervous system (CNS) disorders, infectious diseases, etc. As compared with small-molecule drugs, nanomedicines have unique physicochemical properties and can be used for diverse therapeutic purposes. State-of-the-art technologies provide new tools for the development of nanomedicines with enhanced efficacy and safety. For instance, advances in material sciences offer versatile nanomaterials for developing multifunctional nanomedicines. These nanomedicines can be spatiotemporally controlled for extended blood circulation, sustained release, immune evasion, tissue penetration, sub-organelle targeting, and imaging. Moreover, the nanomedicines that integrate different therapeutic modalities, such as photodynamic therapy (PDT) and chemodynamic therapy (CDT), typically show enhanced therapeutic effects.
This Special Issue aims to highlight recent advances in the development of nanomedicines. Nanomedicines with novel strategies, novel materials, and/or novel therapeutic targets will be well illustrated by eminent scientists, as well as several emerging young scientists, in the field of nanomedicines.
We welcome contributions in the form of reviews or original research articles on the topics of nanomedicines, including, but not limited to, the following fields:
- Nanomedicines beyond the enhanced permeability and retention (EPR) effect
- Nanomedicines for targeted drug delivery
- Stimuli-responsive nanomedicines
- Bio-inspired nanomaterials
- Organic-inorganic nanomaterials
- Peptide self-assembly
- Analytic techniques for characterizing nanomedicines
Dr. Yi Hu
Dr. Jun Chen
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug delivery
- peptide self-assembly
- analytic techniques
- inorganic nanomaterials